Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Benicar Lawsuit Filed Over Hospitalization Following Chronic Diarrhea June 13, 2014 Irvin Jackson Add Your Comments A New Jersey woman is the latest in a growing number of individuals nationwide to file a product liability lawsuit claiming that side effects of Benicar caused them to suffer years of chronic diarrhea and other health problems, alleging that the manufacturers of the popular blood pressure drug withheld information about the risk. Â The complaint was filed last week in the Superior Court of New Jersey for Atlantic County by Christy Brooks, naming Daiichi Sankyo and Forest Laboratories as defendants. Allegations raised by Brooks are similar to those brought in other Benicar lawsuits filed since the FDA first issued warnings last year about the link between use of the hypertension drug and a risk of a medical condition known as sprue-like enteropathy, which can result in chronic diarrhea, weight loss, colitis and other severe gastrointestinal problems. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Prior to the warnings, many Benicar users had been suffering from these complications for years without realizing that the problems may be caused by the medication. In many cases, the Benicar problems were misdiagnosed as celiac disease or unclassified sprue, resulting in continued use of the medication, which could leave users with long-term intestinal damage. Brooks indicates that she was prescribed Benicar in 2005. Following use of the medication, she indicates that she developed enteropathy, several forms of colitis, chronic diarrhea, weight loss, nausea, vomiting, malnutrition and dehydration, which continued for several years. She underwent a number of unsuccessful treatments, which did not alleviate her problems. Like many other doctors, Brooks indicates that her physician was unaware of the link between Benicar and diarrhea problems, which can surface months or even years after an individual starts using the medication. Although Benicar has been on the market for more than a decade, the first reports suggesting a link between the medication and sprue-like enteropathy were not published until July 2012, when independent researchers from the Mayo Clinic identified a number of cases among patients treated at clinics nationwide. In a report published in the medical journal Mayo Clinic Proceedings, researchers outlined cases involving at least 22 patients from 17 different states who were treated for symptoms consistent with celiac disease while taking Benicar. While treatments for celiac disease were ineffective, the report found that once patients stopped taking their blood pressure medication, the symptoms usually resolved. In July 2013, the FDA issued a drug safety communication on the issue, providing information to the medical community for the first time about the risk of sprue-like enteropathy from Benicar. The federal drug regulators indicated that they found clear evidence of a cause and effect relationship between the drug and the gastrointestinal problems, with issues often stopping when the medication was no longer used and resuming if the treatment restarts. Although the diarrhea symptoms from Benicar typically resolve when the medication is no longer used, the problems can cause permanent damage to the intestines, known as villous atrophy. This involves the deterioration or decay of the villa in the intestinal tract, which may prevent the absorption of nutrients and reduce digestive capabilities. Left untreated, villous atrophy may result in dehydration, malnutrition, a weakened ability to fight off other illness and electrolyte problems. Like other complaints filed in recent months, Brooks accuses Daiichi Sankyo and Forest Laboratories of failing to warn patients and the medical community about these potential Benicar side effects, alleging that the drug makers were more interested in profit than ensuring their drugs were safe. “The U.S. market for hypertension treatment is massive. Approximately 73 million people in the United States age 20 and older have hypertension, about 61 percent of which (or 45 million) are under treatment,” the lawsuit notes. “Daiichi Sankyo and Forest distributed marketing materials to physicians and other consumers claiming that its olmesartan products were superior, more effective, and safer than other antihypertensive drug products available.” The lawsuit presents claims against the manufacturers for designing a defective product, failure to warn, strict liability, gross negligence, negligence, negligent misrepresentation, fraud, breach of warranty, violating consumer protection laws and other charges. the lawsuit seeks both compensatory and punitive damages. Tags: Benicar, Daiichi Sankyo, Forest Laboratories, Hypertension, Sprue More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025) Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025) Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)